FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015027609> ?p ?o ?g. }

• W3015027609 endingPage "160" @default.
• W3015027609 startingPage "153" @default.
• W3015027609 abstract "Aicardi Goutières Syndrome (AGS) is a severe, autoinflammatory leukodystrophy characterized by global neurologic dysfunction. Our goal was to create an easy-to-apply scale relevant to the unique developmental challenges associated with AGS.All individuals were recruited through our natural history study. Individuals were classified by AGS severity as mild, moderate, or severe, and clinical encounters were assigned a composite score for neurologic function calculated from the sum of three functional classification scales. Through expert consensus, we identified 11 key items to reflect the severity of AGS across gross motor, fine motor, and cognitive skills to create the AGS Scale. There was strong interrater reliability. The AGS scale was applied across available medical records to evaluate neurologic function over time. The AGS scale was compared to performance on a standard measure of gross motor function (Gross Motor Function Measure-88, GMFM-88) and a putative diagnostic biomarker of disease, the interferon signaling gene expression score (ISG).The AGS scale score correlated with severity classifications and the composite neurologic function scores. When retrospectively applied across our natural history study, the majority of individuals demonstrated an initial decline in function followed by stable scores. Within the first 6 months of disease, the AGS score was the most dynamic. The AGS scale correlated with performance by the GMFM-88, but did not correlate with ISG levels.This study demonstrates the utility of the AGS scale as a multimodal tool for the assessment of neurologic function in AGS. The AGS scale correlates with clinical severity and with a more labor-intensive tool, GMFM-88. This study underscores the limitations of the ISG score as a marker of disease severity. With the AGS scale, we found that AGS neurologic severity is the most dynamic early in disease. This novel AGS scale is a promising tool to longitudinally follow neurologic function in this unique population." @default.
• W3015027609 created "2020-04-10" @default.
• W3015027609 creator A5002520132 @default.
• W3015027609 creator A5004600852 @default.
• W3015027609 creator A5006887738 @default.
• W3015027609 creator A5009347088 @default.
• W3015027609 creator A5013089390 @default.
• W3015027609 creator A5013583390 @default.
• W3015027609 creator A5016188464 @default.
• W3015027609 creator A5017189089 @default.
• W3015027609 creator A5020466771 @default.
• W3015027609 creator A5028899830 @default.
• W3015027609 creator A5044699029 @default.
• W3015027609 creator A5065715672 @default.
• W3015027609 creator A5078491242 @default.
• W3015027609 creator A5083597160 @default.
• W3015027609 date "2020-06-01" @default.
• W3015027609 modified "2023-09-26" @default.
• W3015027609 title "Development of a neurologic severity scale for Aicardi Goutières Syndrome" @default.
• W3015027609 cites W1497089859 @default.
• W3015027609 cites W1995832550 @default.
• W3015027609 cites W2010989450 @default.
• W3015027609 cites W2017760549 @default.
• W3015027609 cites W2023924430 @default.
• W3015027609 cites W2063675796 @default.
• W3015027609 cites W2105879301 @default.
• W3015027609 cites W2111815678 @default.
• W3015027609 cites W2143097947 @default.
• W3015027609 cites W2153132838 @default.
• W3015027609 cites W2522784175 @default.
• W3015027609 cites W2589203314 @default.
• W3015027609 cites W2608562517 @default.
• W3015027609 cites W2738448756 @default.
• W3015027609 cites W2748285143 @default.
• W3015027609 cites W2765483614 @default.
• W3015027609 cites W2789114047 @default.
• W3015027609 cites W2801702920 @default.
• W3015027609 cites W2802138442 @default.
• W3015027609 cites W2890290534 @default.
• W3015027609 cites W2976502661 @default.
• W3015027609 cites W2996886630 @default.
• W3015027609 doi "https://doi.org/10.1016/j.ymgme.2020.03.008" @default.
• W3015027609 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7366613" @default.
• W3015027609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32279991" @default.
• W3015027609 hasPublicationYear "2020" @default.
• W3015027609 type Work @default.
• W3015027609 sameAs 3015027609 @default.
• W3015027609 citedByCount "19" @default.
• W3015027609 countsByYear W30150276092020 @default.
• W3015027609 countsByYear W30150276092021 @default.
• W3015027609 countsByYear W30150276092022 @default.
• W3015027609 countsByYear W30150276092023 @default.
• W3015027609 crossrefType "journal-article" @default.
• W3015027609 hasAuthorship W3015027609A5002520132 @default.
• W3015027609 hasAuthorship W3015027609A5004600852 @default.
• W3015027609 hasAuthorship W3015027609A5006887738 @default.
• W3015027609 hasAuthorship W3015027609A5009347088 @default.
• W3015027609 hasAuthorship W3015027609A5013089390 @default.
• W3015027609 hasAuthorship W3015027609A5013583390 @default.
• W3015027609 hasAuthorship W3015027609A5016188464 @default.
• W3015027609 hasAuthorship W3015027609A5017189089 @default.
• W3015027609 hasAuthorship W3015027609A5020466771 @default.
• W3015027609 hasAuthorship W3015027609A5028899830 @default.
• W3015027609 hasAuthorship W3015027609A5044699029 @default.
• W3015027609 hasAuthorship W3015027609A5065715672 @default.
• W3015027609 hasAuthorship W3015027609A5078491242 @default.
• W3015027609 hasAuthorship W3015027609A5083597160 @default.
• W3015027609 hasConcept C126322002 @default.
• W3015027609 hasConcept C138496976 @default.
• W3015027609 hasConcept C15744967 @default.
• W3015027609 hasConcept C163276114 @default.
• W3015027609 hasConcept C16568411 @default.
• W3015027609 hasConcept C169760540 @default.
• W3015027609 hasConcept C1862650 @default.
• W3015027609 hasConcept C2778279407 @default.
• W3015027609 hasConcept C2781197716 @default.
• W3015027609 hasConcept C30036603 @default.
• W3015027609 hasConcept C55493867 @default.
• W3015027609 hasConcept C61863361 @default.
• W3015027609 hasConcept C71924100 @default.
• W3015027609 hasConcept C83849319 @default.
• W3015027609 hasConcept C86803240 @default.
• W3015027609 hasConcept C99508421 @default.
• W3015027609 hasConceptScore W3015027609C126322002 @default.
• W3015027609 hasConceptScore W3015027609C138496976 @default.
• W3015027609 hasConceptScore W3015027609C15744967 @default.
• W3015027609 hasConceptScore W3015027609C163276114 @default.
• W3015027609 hasConceptScore W3015027609C16568411 @default.
• W3015027609 hasConceptScore W3015027609C169760540 @default.
• W3015027609 hasConceptScore W3015027609C1862650 @default.
• W3015027609 hasConceptScore W3015027609C2778279407 @default.
• W3015027609 hasConceptScore W3015027609C2781197716 @default.
• W3015027609 hasConceptScore W3015027609C30036603 @default.
• W3015027609 hasConceptScore W3015027609C55493867 @default.
• W3015027609 hasConceptScore W3015027609C61863361 @default.
• W3015027609 hasConceptScore W3015027609C71924100 @default.
• W3015027609 hasConceptScore W3015027609C83849319 @default.
• W3015027609 hasConceptScore W3015027609C86803240 @default.

• next